Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
mirabegron (myrbetriq) (1 trial)
Cystitis (Phase 3)
Cystitis, Interstitial (Phase 3)
Trials (1 total)
Trial APIs (1 total)